AGI First Quarter 2019 Results Release and Conference Call
WINNIPEG, April 18, 2019 /CNW/ - Ag Growth International Inc. ("AGI") (TSX: AFN) will hold a conference call on Tuesday, May 7, 2019, at 8:30 a.m. EDT to discuss its results for the three months ended March 31, 2019. A news release announcing AGI's results will be issued before markets open on May 7, 2019.
To participate in the conference call, please dial 1-888-390-0605 or for local access dial 416-764-8609. An audio replay of the call will be available for seven days. To access the audio replay, please dial 1-888-390-0541 or for local access dial 416-764-8677. Please quote passcode 736149# for the audio replay.
AGI Company Profile
AGI is a leading provider of equipment solutions for agriculture bulk commodities including seed, fertilizer, grain, feed and food processing systems. AGI has manufacturing facilities in Canada, the United States, the United Kingdom, Brazil, France, Italy and India, and distributes its product globally.
Further information can be found in the disclosure documents filed by AGI with the securities regulatory authorities, available at www.sedar.com and on AGI's website www.aggrowth.com.
Galantas Gold Corporation (the ?Company') is pleased to announce its audited annual financial results for the year ended December 31, 2023. A copy of the Financial Statements and Management Discussion and Analysis will be sent to shareholders in due...
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.
The earnings release can be found at...
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. .
Juniper Re will...
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...
